Novo Nordisk and MATTER announce winners of Novo Nordisk Innovation Challenge
Adelie Health, Human Capital Works, Medopad, Simple C and Xbird awarded $25,000, begin accelerator program at MATTER in January
Boston, MA, December 6, 2018 — MATTER and Novo Nordisk announced the winners of the 2018–19 Novo Nordisk Innovation Challenge. The winning teams are Adelie Health, Human Capital Works, Medopad, Simple C and Xbird.
The Novo Nordisk Innovation Challenge, announced in September, called on innovators to develop ways to use data generated by Novo Nordisk’s marketed pen injectors to improve the care of, and quality of life for, people living with diabetes. Twelve semi-finalists were selected from a competitive pool of applicants.
The semi-finalists attended an innovation bootcamp hosted by MATTER in November to further refine their concepts in advance of today’s pitch event. The finalists presented their solution at the Joseph B. Martin Conference Center at Harvard Medical School to a panel of judges.
“Congratulations to all of the challenge semi-finalists. Their creative ideas for using digital technology to improve diabetes care are inspiring,” said Thomas Miller, vice president at Novo Nordisk. “We are excited to see what happens over this next year, as we combine the wisdom of Novo Nordisk with the power of MATTER’s community and programs to help the winning teams further develop their solutions and get them into the hands of the people who need them.”
The five winning teams were each awarded $25,000 and the opportunity to co-develop their solution with Novo Nordisk, beginning with an intensive, semi-virtual accelerator program developed by MATTER.
“The winning teams demonstrate some of the powerful new ways to harness data to improve diabetes management,” said MATTER CEO Steven Collens. “MATTER applauds Novo Nordisk’s commitment to working hand-in-hand with startups and we look forward to collaborating with both Novo Nordisk and the winning teams to accelerate their solutions over the next year.”
About the winners
Adelie Health has developed a replacement pen cap that fits on to all prefilled insulin pens. The cap includes reminders and alarms, a sensor to detect usage and Bluetooth to send data to a smart device.
HumanCapitalWorks proposed Emmett, a digital health solution for parents and caregivers of patients with Type 1 diabetes that combines continuous streams of data from IoT devices with a voice-enabled interface to reduce the cognitive burden, anxiety and fear associated with the critical decisions made during management of the disease.
Medopad offers a remote monitoring solution with modular functionality that provides clinicians, caregivers and patients continuous visibility to enable earlier detection of health problems and create the opportunity for clinicians to engage with patients to support and achieve optimal glycaemic control.
SimpleC a platform powered by AI to deliver ongoing, individualized, evidence-based digital therapeutics for seniors living with varying states of cognitive impairment and diabetes. Their solution is designed to help maintain adherence to their care plan, as well as incorporate provider and caregiver involvement.
xBird employs machine learning algorithms to analyze micro-movements and other data collected by sensors built into people’s smartphones and wearables. The technology creates a journey map of a person’s day, highlighting those activities that happened in the context of hypo- and hyperglycemic events.
About MATTER
At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 200 cutting-edge startups from around the world, working together with hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives. For more information, visit matter.health and follow @MATTERhealth.